Maternal serum screening marker levels in women with a previous aneuploidy pregnancy

Prenatal Diagnosis

Volumn 29, Issue 13, 2009, Pages 1242-1243

  Spencer, Kevin ^a   Staboulidou, Ismini ^b   De Jesus Cruz, Jader ^b   Karagiannis, George ^b   Nicolaides, Kypros H ^b  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Down's syndrome; First trimester; Free hCG; PAPP A; Trisomy

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ALGORITHM; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ANEUPLOIDY; BIOLOGICAL MARKERS; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 73449091208     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2395     Document Type: Article

References (4)

1. Cuckle HS, Arbuzova S. 2004. Multianalyte maternal serum screening for chromosomal defects. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (5th edn), Milunskey A (ed). Johns Hopkins University Press: Baltimore; 795-835.
2. Cuckle HS, Spencer K, Nicolaides KH. 2005. Down syndrome screening marker levels in women with a previous aneuploidy pregnancy. Prenat Diagn 25: 47-50.
3. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. 2008. First trimester screening for trisomy 21 by free beta human chorionic gonadotropin and pregnancy associated plasma protein A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31: 493-502.
4. Nicolaides KH, Sebire NJ, Snijders RJM. 1999. The 11-14 weeks scan. The Diagnosis of Fetal Abnormalities. Parthenon: New York.